본문 바로가기
KERD
논문KCI 등재

Leptin, Neuropeptide Y and Islet Amyloid Polypeptide Levels in Obese Children

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류소아과학

초록

Purpose: The aim of this study was to compare serum leptin, neuropeptide Y (NPY), and islet amyloid polypeptide (amylin) levels in obese and normal weight children, and to investigate their correlations with anthropometric parameters and metabolic bio-marker levels. Methods: Body mass index (BMI), waist and hip circumference, blood pressure (systolic/diastolic), lipid profile, fasting glucose, and serum insulin, leptin, NPY, and amylin levels were measured in 56 children (24 obese children and 32 non-obese controls). Homeostatic model assessment-insulin resistance (HOMA-IR) values were calculated and the relationships between anthropometric variables, metabolic biomarkers, and diet-regulating factors (leptin, NPY, and amylin levels) were examined. Results: BMI, hip circumference, waist circumference, and systolic and diastolic pressure were significantly higher in the obese group than in the non-obese group (p<0.0001). Total cholesterol, triglyceride, low-density lipoprotein -cholesterol, glucose, and insulin levels were also significantly higher in the obese group (p<0.05). On the other hand, high-density lipoprotein-cholesterol levels were higher in the non-obese group , but this was not significant. Serum leptin, NPY, and amylin levels were significantly higher in the obese group (p<0.05). Furthermore, in the obese group, leptin levels were found to be significantly correlated with BMI (r=0.379, p=0.043), and NPY levels (r=0.377, p=0.044), and amylin levels were found to be significantly correlated with insulin levels (r=0.400, p=0.048), and HOMA-IR (r=0.459, p=0.028). Conclusion: Metabolic risk factor alterations are present in obese children, and these children show abnormalities in the diet regulatory system caused by leptin, NPY, and amylin resistance. Of particular note, amylin was found to be positively correlated with insulin resistance.

Abstract

Purpose: The aim of this study was to compare serum leptin, neuropeptide Y (NPY), and islet amyloid polypeptide (amylin) levels in obese and normal weight children, and to investigate their correlations with anthropometric parameters and metabolic bio-marker levels. Methods: Body mass index (BMI), waist and hip circumference, blood pressure (systolic/diastolic), lipid profile, fasting glucose, and serum insulin, leptin, NPY, and amylin levels were measured in 56 children (24 obese children and 32 non-obese controls). Homeostatic model assessment-insulin resistance (HOMA-IR) values were calculated and the relationships between anthropometric variables, metabolic biomarkers, and diet-regulating factors (leptin, NPY, and amylin levels) were examined. Results: BMI, hip circumference, waist circumference, and systolic and diastolic pressure were significantly higher in the obese group than in the non-obese group (p<0.0001). Total cholesterol, triglyceride, low-density lipoprotein -cholesterol, glucose, and insulin levels were also significantly higher in the obese group (p<0.05). On the other hand, high-density lipoprotein-cholesterol levels were higher in the non-obese group , but this was not significant. Serum leptin, NPY, and amylin levels were significantly higher in the obese group (p<0.05). Furthermore, in the obese group, leptin levels were found to be significantly correlated with BMI (r=0.379, p=0.043), and NPY levels (r=0.377, p=0.044), and amylin levels were found to be significantly correlated with insulin levels (r=0.400, p=0.048), and HOMA-IR (r=0.459, p=0.028). Conclusion: Metabolic risk factor alterations are present in obese children, and these children show abnormalities in the diet regulatory system caused by leptin, NPY, and amylin resistance. Of particular note, amylin was found to be positively correlated with insulin resistance.

참고문헌 (41)

  1. Strauss RS, "Epidemic increase in childhood overweight, 1986-1998", JAMA, 286, pp.2845~2848 (2001)
  2. Sinaiko AR, "Relation of weight and rate of increase in weight during childhood and adolescence to body size, blood pressure, fasting insulin, and lipids in young adults. The Minneapolis Children's Blood Pressure Study", Circulation, 99, pp.1471~1476 (1999)
  3. Blum WF, "Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone", J Clin Endocrinol Metab, 82, pp.2904~2910 (1997)
  4. Zhang Y, "Positional cloning of the mouse obese gene and its human homologue", Nature, 372, pp.425~432 (1994)
  5. Saranac L, "Orexitropic signaling proteins in obese children", ScientificWorldJournal, 7, pp.1263~1271 (2007)
  6. Clément K, "A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction", Nature, 392, pp.398~401 (1998)
  7. Schwartz MW, "Central nervous system control of food intake", Nature, 404, pp.661~671 (2000)
  8. Yang K, "Neuropeptide Y is produced in visceral adipose tissue and promotes proliferation of adipocyte precursor cells via the Y1 receptor", FASEB J, 22, pp.2452~2464 (2008)
  9. Reinehr T, "Insulin sensitivity among obese children and adolescents, according to degree of weight loss", Pediatrics, 114, pp.1569~1573 (2004)
  10. 백설향, "비만어린이와 정상체중 어린이의 행동 특성에 관한 문헌적", 대한지역사회영양학회지, 13(3), pp.386~395 (2008), 대한지역사회영양학회
  11. Stanley S, "Hormonal regulation of food intake", Physiol Rev, 85, pp.1131~1158 (2005)
  12. Considine RV, "Serum immunoreactive-leptin concentrations in normal-weight and obese humans", N Engl J Med, 334, pp.292~295 (1996)
  13. Campfield LA, "The OB protein (leptin) pathway--a link between adipose tissue mass and central neural networks", Horm Metab Res, 28, pp.619~632 (1996)
  14. Roemmich JN, "Role of leptin during childhood growth and development", Endocrinol Metab Clin North Am, 28, pp.749~764 (1999)
  15. Park KG, "Relationship between serum adiponectin and leptin concentrations and body fat distribution", Diabetes Res Clin Pract, 63, pp.135~142 (2004)
  16. Allen YS, "Neuropeptide Y distribution in the rat brain", Science, 221, pp.877~879 (1983)
  17. Stanley BG, "Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity", Peptides, 7, pp.1189~1192 (1986)
  18. Billington CJ, "Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism", Am J Physiol, 260, pp.321~327 (1991)
  19. Fekete C, "Agouti-related protein (AGRP) has a central inhibitory action on the hypothalamic-pituitary-thyroid (HPT) axis; comparisons between the effect of AGRP and neuropeptide Y on energy homeostasis and the HPT axis", Endocrinology, 143, pp.3846~3853 (2002)
  20. Moltz JH, "Neuropeptide Y: direct and indirect action on insulin secretion in the rat", Peptides, 6, pp.1155~1159 (1985)
  21. Yi CX, "Glucocorticoid signaling in the arcuate nucleus modulates hepatic insulin sensitivity", Diabetes, 61, pp.339~345 (2012)
  22. Rohner-Jeanrenaud F, "The loop system between neuropeptide Y and leptin in normal and obese rodents", Horm Metab Res, 28, pp.642~648 (1996)
  23. Smith FJ, "Feeding inhibition by neuropeptide Y", Nature, 381, pp.415~418 (1996)
  24. Young A, "Roles of amylin in diabetes and in regulation of nutrient load", Nutrition, 14, pp.524~527 (1998)
  25. Chapman I, "Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes", Diabetologia, 48, pp.838~848 (2005)
  26. Hollander P, "Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients", Obes Res, 12, pp.661~668 (2004)
  27. Lutz TA, "Amylinergic control of food intake", Physiol Behav, 89, pp.465~471 (2006)
  28. Hillebrand JJ, "Do leptin and insulin signal adiposity?", Forum Nutr, 63, pp.111~122 (2010)
  29. Schwartz MW, "Is the energy homeostasis system inherently biased toward weight gain?", Diabetes, 52, pp.232~238 (2003)
  30. Woods SC, "Gastrointestinal satiety signals I. An overview of gastrointestinal signals that influence food intake", Am J Physiol Gastrointest Liver Physiol, 286, pp.7~13 (2004)
  31. Lutz TA, "Amylin decreases meal size in rats", Physiol Behav, 58, pp.1197~1202 (1995)
  32. Mollet A, "Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats", Physiol Behav, 81, pp.149~155 (2004)
  33. Reidelberger RD, "Amylin receptor blockade stimulates food intake in rats", Am J Physiol Regul Integr Comp Physiol, 287, pp.568~574 (2004)
  34. Woods SC, "Signals that influence food intake and body weight", Physiol Behav, 86, pp.709~716 (2005)
  35. Roth JD, "Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression", Endocrinology, 147, pp.5855~5864 (2006)
  36. Crawley JN, "Rapid development of tolerance to the behavioural actions of cholecystokinin", Nature, 302, pp.703~706 (1983)
  37. Arnelo U, "Chronic infusion of islet amyloid polypeptide causes anorexia in rats", Am J Physiol, 271, pp.1654~1659 (1996)
  38. Lutz TA, "The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema", nucleus of the solitary tract (AP, Int J Obes Relat Metab Disord, pp.2001, 25[DOI]
  39. Ravussin E, "Enhanced weight loss with pramlintide", metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy, 2009, pp.17, 1736~1743
  40. Roth JD, "Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies", Proc Natl Acad Sci U S A, 105, pp.7257~7262 (2008)
  41. Speiser PW, "Obesity Consensus Working Group. Childhood obesity", J Clin Endocrinol Metab, 90, pp.1871~1887 (2005)

관련 논문AI추천

The Relationship of Leptin (+19) AG, Leptin (2548) GA, and Leptin Receptor Gln223Arg Gene Polymorphisms with Obesity and Metabolic Syndrome in Obese Children and AdolescentsEmel Ensari, Erhan Karaslan, Ömer Ateş, Osman Demir, Resul Yılmaz, Samet Özer, Serap Bilge대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2021 · 제24권 제3호소아 비만에서 Leptin, Adiponectin 및 Leptin/Adiponectin Ratio와 대사 장애의 연관성에 관한 연구김은영, 문경래, 조성종대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2006 · 제9권 제1호Leptin and adiponectin levels in girls with central precocious puberty before and during GnRH agonist treatment임한혁, Chun Woo Song, Jae Won Yoo대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2016 · 제21권 제4호Birth weight was negatively correlated with plasma ghrelin, insulin resistance, and coenzyme Q10 levels in overweight children박은주한국영양학회 · Nutrition Research and Practice2010 · 제4권 제4호Different Criteria for the Definition of Insulin Resistance and ItsRelation with Dyslipidemia in Overweight and Obese Childrenand AdolescentsCarlos Alberto Nogueira-de-Almeida, Elza Daniel de Mello대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2018 · 제21권 제1호Serum osteocalcin levels in overweight childrenHyo-Kyoung Nam, Kee-Hyoung Lee, Seok Bin Oh, Won Young Lee, Young-Jun Rhie대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2019 · 제24권 제2호

이 간행물의 다른 논문 (9건)